Olympus Announces Launch of Olympus Asia Pacific Innovation Program
2022年12月5日 - 9:00AM
JCN Newswire
Olympus Corporation (Olympus), a global medtech company
committed to making people's lives healthier, safer and more
fulfilling, has partnered with MedTech Innovator Asia Pacific, the
industry's largest healthcare accelerator, to facilitate the
Olympus Asia Pacific Innovation Program (OAIP) running throughout
2023.
Over a century old, Olympus has a rich heritage in the field of
medical device innovation, having made a substantial impact on
lives, with a portfolio of solutions that provide treatment for
approximately 100[1] diseases or conditions, including the top
four[2] of five cancers by global incidence rates. Olympus believes
that the emergence of new technologies, particularly those within
the digital realm, will revolutionize the patient care paradigm.
Patient outcomes will be improved by optimizing the care pathway
for individual patients based on their unique needs.
Olympus invites visionary startups to contribute to this revolution
by participating in the OAIP and submitting their technologies that
play a meaningful role in the advancement of minimally invasive
care and new ways to detect, monitor, and treat conditions and
diseases. Shortlisted startups will be invited to pitch across
various in-person and virtual pitch events in front of Olympus
executives and leaders over two phases from May 2023 to September
2023, with the winning innovator receiving grant funding of $75,000
as well as an exclusive mentorship program with key thought leaders
from within Olympus.
Felicia Chung, Olympus Business Development Leader for the Asia
Pacific region said "I am pleased to announce Olympus' first-ever
Innovation Program that seeks to identify and collaborate with
innovators in the very exciting medtech space. APAC is a hotbed of
innovative and bold ideas, especially in the space of digital
solutions, and we are excited to uncover promising technologies
that positively impact human health and create tangible value for
providers and patients. We look forward to kick-starting this
program and to playing a meaningful role in the advancement of
minimally invasive care by identifying new ways to detect, monitor,
and treat conditions and diseases."
Marc Radatt, CEO for Olympus Corporation of Asia Pacific Limited
and board member of the Asia Pacific Medical Technology Association
(APACMed), said "Olympus is proud to have partnered with MedTech
Innovator Asia Pacific in pursuit of new ideas that will
revolutionize patient outcomes and increase access to new
technologies through the OAIP. Initiatives like these promote
industry wide collaboration, and access to valuable funding and
mentorships that result in meaningful change and facilitate greater
medtech thought leadership across our region."
To apply for the OAIP, please visit:
https://medtechinnovator.org/olympusapac2023/
Participation Criteria
Visionaries are invited to submit solutions that play a meaningful
role in the advancement of minimally invasive care and new ways to
detect, monitor, and treat conditions and diseases. Of particular
interest are technologies focused on cancers and diseases of the
stomach, colon, and lungs, and within the urology specialty.
Examples may include:
- Smart endoscopy, enabling early detection and advanced
endoluminal therapy/treatment
- Robotics, sensing, monitoring, and navigation technology for
future autonomy in minimally invasive
diagnosis/surgery/treatment
- Transformation of the patient care pathway from pre-surgery
planning through post-surgical care, supported by, for example:
-- AI for clinical efficiency & predictive analysis
-- 3D/4D image reconstruction for surgical procedures
- Novel device/procedural solutions that may replace current
procedures or offer an alternative to drug treatments
- Innovations that enable non- or less-invasive diagnosis, surgery,
and treatment
- Ethical AI / digitally enabled technologies
- Next-generation automated documentation
- Smart gastro clinics and remote patient monitoring related to gut
health
Through the OAIP, Olympus aims to identify the next revolutionary
solution that will help to elevate the standard of care for
patients globally, in line with Olympus' purpose of making people's
lives safer, healthier and more fulfilling.
About Olympus
As a leading medical technology company, Olympus' Medical Business
uses innovative capabilities in medical technology, therapeutic
intervention, and precision manufacturing to help healthcare
professionals deliver diagnostic, therapeutic, and minimally
invasive procedures to improve clinical outcomes, reduce overall
costs, and enhance the quality of life for patients. Olympus'
Medical portfolio includes endoscopes, laparoscopes, and video
imaging systems, as well as surgical energy devices, customer
solutions, medical services, and a wide range of endotherapy
instruments for endoscopic and therapeutic applications. For more
information, visit www.olympus-global.com and follow our global
Twitter account: @Olympus_Corp.
About MedTech Innovator
Based in Los Angeles, Calif., MedTech Innovator is the largest
accelerator of medical device companies in the world and the
premier startup accelerator in the medical technology industry. Its
mission is to improve the lives of patients by accelerating the
growth of companies that are transforming the health care system.
MedTech Innovator matches health care industry leaders with
innovative early stage and emerging-growth medtech companies for
mentorship and support. To date, MedTech Innovator has supported
509 alumni that have gone on to raise $6 billion in follow-on
funding, and brought more than 200 products to regulatory clearance
or approval. For more information, visit MedTech Innovator and
follow @MedTechAwards on Twitter and MedTech Innovator on LinkedIn.
To receive industry insights and highlights about MedTech
Innovator's current and alumni participant companies, subscribe to
its monthly newsletter. https://medtechinnovator.org/
[1] As of March 2022
[2] Lung, stomach, colon, and prostate cancers - the top four
highest incidence of cancers excluding breast cancer, as of March
2022. Source: GLOBAL CAN 2020
Copyright 2022 JCN Newswire . All rights reserved.